Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 5Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Myeloid 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Postural Orthostatic Tachycardia Syndrome 1Pancreatic carcinoma, familial 1Pancreatic cancer, adult 1Mastocytosis 1Lung Cancer Screening 1Leukemia, Myelomonocytic, Chronic 1Bronchopulmonary Disease 1

Interventions

Specimen Handling 311Magnetic Resonance Spectroscopy 266pembrolizumab 251Carboplatin 184Cyclophosphamide 176Biopsy 172Cisplatin 157Gemcitabine 134Paclitaxel 131Bevacizumab 124fludarabine 117Radiotherapy 108Nivolumab 108Oxaliplatin 88Docetaxel 87Fluorouracil 85Capecitabine 83venetoclax 82Dexamethasone 77Pemetrexed 72Rituximab 71Leucovorin 69Drug Therapy 69atezolizumab 67durvalumab 66Radiosurgery 65Blood Specimen Collection 65Standard of Care 63Doxorubicin 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Mass Screening × 90 days × Clear all
NCT06439901 2026-06-02

OPTI-DEPIST

Institut Curie

Phase NA Recruiting
500 enrolled

Bronchopulmonary Disease

NCT06042543 2026-06-01

EASTER

International Agency for Research on Cancer

Phase NA Recruiting
3,200 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07143669 2026-05-22

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Blueprint Medicines Corporation

Recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

NCT05006131 2026-04-23

PancreasScan

Beth Israel Deaconess Medical Center

Recruiting
1,395 enrolled
Gastrointestinal

Pancreatic cancer, adult, Pancreatic carcinoma, familial

NCT07408531 2026-04-13

LUNG-07: Advancing Precision-Based Lung Cancer Screening: Implementation, AI-Guided Risk Stratification, and Biomarker Integration (CREST AI)

University of Illinois at Chicago

Phase NA Recruiting
2,500 enrolled
Thoracic

Lung Cancer Screening

Data powered by HemOnc (CC BY 4.0) Colophon âš¡